AXSOME THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
AXSOME THERAPEUTICS, INC. (AXSM) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $4.79 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-10
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4.79M.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.19M.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.61M.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.08M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-06-30 | $4.79M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $5.19M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $5.61M 10-K · filed 2026-02-23 | |
| 2025-09-30 | $6.08M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $6.52M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $6.96M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $2.15M 10-K · filed 2025-02-18 | |
| 2024-09-30 | $2.40M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.64M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $2.88M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $3.14M 10-K · filed 2024-02-23 | |
| 2023-09-30 | $3.43M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $3.67M 10-Q · filed 2023-08-07 | |
| 2022-12-31 | $3.20K 10-K · filed 2023-02-28 | |
| 2022-09-30 | $3.12K 10-Q · filed 2022-11-07 | |
| 2022-03-31 | $10.88K 10-Q · filed 2022-08-09 | $22.75K 10-Q · filed 2022-05-02 |
| 2021-12-31 | $9.32K 10-K · filed 2022-03-01 | |
| 2021-09-30 | $19.88K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $34.30K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $53.55K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $77.70K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |